Skye Bioscience, Inc. (SKYE)
Nasdaq: SKYE · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2011
Who owns Skye Bioscience, Inc.
As filed with the SECHolders of 5% or more
2
Andrew J. Schwab holds 26.1% of Common Stock, par value $0.001 per share, as its SCHEDULE 13D/A filed Sep 24, 2026 says.
Directors and officers
11
report now, of 24 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Andrew J. Schwab
SCHEDULE 13D/A · filed Sep 24, 2026 · Common Stock, par value $0.001 per share · 30.2% in Aug 18, 2026
Tang Capital Management, LLC
SCHEDULE 13G · filed Oct 14, 2026 · Common Stock, par value $0.001
Sphera Funds Management Ltd.
SCHEDULE 13G/A · filed Apr 10, 2025 · Common Stock, Par Value $0.001 · reported falling below 5%
Schonfeld Strategic Advisors LLC
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.22% in May 15, 2025
What SKYE reports owning in othersstakes of 5% or more, and other ties
4 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 10, 2026.
Insider tradesForm 4
15sales
0purchases
0sales on a scheduled plan
1people selling
$400,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 37 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Schwab Andrew J. | director | 15 | $400,000 | 0 | 0 | $0 |
| 5am Ventures II LP | 10% owner | 4 | $200,000 | 0 | 0 | $0 |
| 5am Partners II, LLC | 10% owner | 9 | $100,000 | 0 | 0 | $0 |
| Parmar Kush | 10% owner | 2 | $100,000 | 0 | 0 | $0 |